Halobetasol
Ulobetasol is a highly potent corticosteroid. It is structurally related to [clobetasol]. Due to its high potency, it is mainly prescribed in the treatment of severe plaque psoriasis and corticosteroid responsive dermatoses.  Ulobetasol was granted FDA approval on 17 December 1990.